2 0 1 0 1 B-lower_bound
or 2 4 2 4 O
more 5 9 5 9 O
high 10 14 10 14 B-clinical_variable
dose 15 19 15 19 I-clinical_variable
radiation 20 29 20 29 I-clinical_variable
scans 30 35 30 35 I-clinical_variable
in 36 38 36 38 O
the 39 42 39 42 O
past 43 47 43 47 B-upper_bound
year 48 52 48 52 I-upper_bound
( 53 54 53 54 O
CT 54 56 54 56 B-treatment
scan 57 61 57 61 I-treatment
with 62 66 62 66 I-treatment
contrast 67 75 67 75 I-treatment
, 75 76 75 76 O
angiogram 77 86 77 86 B-treatment
, 86 87 86 87 O
SPECT 88 93 88 93 B-treatment
nuclear 94 101 94 101 I-treatment
medicine 102 110 102 110 I-treatment
scan 111 115 111 115 I-treatment
, 115 116 115 116 O
myocardial 117 127 117 127 B-treatment
/ 127 128 127 128 I-treatment
cardiac 128 135 128 135 I-treatment
perfusion 136 145 136 145 I-treatment
scan 146 150 146 150 I-treatment
) 150 151 150 151 O

Baseline 0 8 152 160 O
: 8 9 160 161 O
liver 10 15 162 167 B-chronic_disease
, 15 16 167 168 O
renal 17 22 169 174 B-chronic_disease
or 23 25 175 177 O
blood 26 31 178 183 B-chronic_disease
count 32 37 184 189 I-chronic_disease
abnormalities 38 51 190 203 I-chronic_disease
, 51 52 203 204 O
Glucose-6 53 62 205 214 B-chronic_disease
- 62 63 214 215 I-chronic_disease
phosphate 63 72 215 224 I-chronic_disease
dehydrogenase 73 86 225 238 I-chronic_disease
( 87 88 239 240 I-chronic_disease
G6PD 88 92 240 244 I-chronic_disease
) 92 93 244 245 I-chronic_disease
deficiency 94 104 246 256 I-chronic_disease

Cancer 0 6 257 263 B-cancer
treated 7 14 264 271 O
in 15 17 272 274 O
the 18 21 275 278 O
last 22 26 279 283 B-upper_bound
5 27 28 284 285 I-upper_bound
years 29 34 286 291 I-upper_bound
( 35 36 292 293 O
except 36 42 293 299 O
basal 43 48 300 305 B-cancer
and 49 52 306 309 O
squamous 53 61 310 318 B-cancer
cell 62 66 319 323 I-cancer
) 66 67 323 324 O
or 68 70 325 327 O
any 71 74 328 331 O
lymphoma 75 83 332 340 B-cancer
or 84 86 341 343 O
melanoma 87 95 344 352 B-cancer

Current 0 7 353 360 O
use 8 11 361 364 O
of 12 14 365 367 O
> 15 16 368 369 O
10 16 18 369 371 B-lower_bound
mg 18 20 371 373 I-lower_bound
per 21 24 374 377 I-lower_bound
day 25 28 378 381 I-lower_bound
of 29 31 382 384 O
prednisone 32 42 385 395 B-treatment

Disease 0 7 396 403 B-clinical_variable
Activity 8 16 404 412 I-clinical_variable
Score-28 17 25 413 421 I-clinical_variable
> 26 27 422 423 O
3.2 28 31 424 427 B-lower_bound

HIV 0 3 428 431 B-chronic_disease

Hepatitis 0 9 432 441 B-chronic_disease
B 10 11 442 443 I-chronic_disease
Virus 12 17 444 449 I-chronic_disease

Hepatitis 0 9 450 459 B-chronic_disease
C 10 11 460 461 I-chronic_disease
Virus 12 17 462 467 O

Insulin 0 7 468 475 B-chronic_disease
- 7 8 475 476 I-chronic_disease
dependent 8 17 476 485 I-chronic_disease
or 18 20 486 488 O
uncontrolled 21 33 489 501 B-chronic_disease
diabetes 34 42 502 510 I-chronic_disease
mellitus 43 51 511 519 I-chronic_disease
( 52 53 520 521 I-chronic_disease
DM 53 55 521 523 I-chronic_disease
) 55 56 523 524 I-chronic_disease

Intra 0 5 525 530 B-treatment
- 5 6 530 531 I-treatment
articular 6 15 531 540 I-treatment
injection 16 25 541 550 I-treatment
within 26 32 551 557 O
the 33 36 558 561 O
4 37 38 562 563 B-upper_bound
weeks 39 44 564 569 I-upper_bound
prior 45 50 570 575 I-upper_bound
to 51 53 576 578 I-upper_bound
baseline 54 62 579 587 I-upper_bound
FDG 63 66 588 591 O
PET 67 70 592 595 O
/ 70 71 595 596 O
CT 71 73 596 598 O

MTX 0 3 599 602 B-treatment
monotherapy 4 15 603 614 I-treatment
for 16 19 615 618 O
≥ 20 21 619 620 O
8 22 23 621 622 B-lower_bound
weeks 24 29 623 628 I-lower_bound
at 30 32 629 631 O
≥ 33 34 632 633 O
15 35 37 634 636 B-lower_bound
mg 37 39 636 638 I-lower_bound
weekly 40 46 639 645 O
or 47 49 646 648 O
≥ 50 51 649 650 O
7.5 52 55 651 654 B-lower_bound
mg 56 58 655 657 I-lower_bound
weekly 59 65 658 664 O
with 66 70 665 669 O
a 71 72 670 671 O
documented 73 83 672 682 O
intolerance 84 95 683 694 O
to 96 98 695 697 O
higher 99 105 698 704 O
doses 106 111 705 710 O

Men 0 3 711 714 B-gender
≥ 4 5 715 716 O
45 6 8 717 719 B-lower_bound
years 9 14 720 725 I-lower_bound

No 0 2 726 728 O
non 3 6 729 732 B-treatment
- 6 7 732 733 I-treatment
biologic 7 15 733 741 I-treatment
DMARDs 16 22 742 748 I-treatment
in 23 25 749 751 O
preceding 26 35 752 761 O
two 36 39 762 765 B-upper_bound
months 40 46 766 772 I-upper_bound
( 47 48 773 774 O
other 48 53 774 779 O
than 54 58 780 784 O
MTX 59 62 785 788 B-treatment
and 63 66 789 792 O
HCQ 67 70 793 796 B-treatment
) 70 71 796 797 O

Prior 0 5 798 803 O
patient 6 13 804 811 O
reported 14 22 812 820 O
, 22 23 820 821 O
physician 24 33 822 831 O
diagnosed 34 43 832 841 O
clinical 44 52 842 850 O
cardiovascular 53 67 851 865 B-chronic_disease
( 68 69 866 867 I-chronic_disease
CV 69 71 867 869 I-chronic_disease
) 71 72 869 870 I-chronic_disease
event 73 78 871 876 I-chronic_disease

Systemic 0 8 877 885 B-chronic_disease
lupus 9 14 886 891 I-chronic_disease
erythematosus 15 28 892 905 I-chronic_disease
( 29 30 906 907 I-chronic_disease
SLE 30 33 907 910 I-chronic_disease
) 33 34 910 911 I-chronic_disease

Use 0 3 912 915 O
of 4 6 916 918 O
a 7 8 919 920 O
high 9 13 921 925 B-treatment
- 13 14 925 926 I-treatment
intensity 14 23 926 935 I-treatment
statin 24 30 936 942 I-treatment
lipid 31 36 943 948 I-treatment
lowering 37 45 949 957 I-treatment
drug 46 50 958 962 I-treatment
or 51 53 963 965 O
PCSK9 54 59 966 971 B-treatment
inhibitor 60 69 972 981 I-treatment
in 70 72 982 984 O
the 73 76 985 988 O
past 77 81 989 993 B-upper_bound
12 82 84 994 996 I-upper_bound
months 85 91 997 1003 I-upper_bound

Use 0 3 1004 1007 O
of 4 6 1008 1010 O
biologic 7 15 1011 1019 B-treatment
DMARD 16 21 1020 1025 I-treatment
within 22 28 1026 1032 O
the 29 32 1033 1036 O
past 33 37 1037 1041 B-upper_bound
6 38 39 1042 1043 I-upper_bound
months 40 46 1044 1050 I-upper_bound
or 47 49 1051 1053 O
use 50 53 1054 1057 O
of 54 56 1058 1060 O
rituximab 57 66 1061 1070 B-treatment
ever 67 71 1071 1075 O

active 0 6 1076 1082 B-chronic_disease
( 7 8 1083 1084 I-chronic_disease
or 8 10 1084 1086 I-chronic_disease
untreated 11 20 1087 1096 I-chronic_disease
latent 21 27 1097 1103 I-chronic_disease
) 27 28 1103 1104 I-chronic_disease
tuberculosis 29 41 1105 1117 I-chronic_disease

demyelinating 0 13 1118 1131 B-chronic_disease
disease 14 21 1132 1139 I-chronic_disease

macular 0 7 1140 1147 B-chronic_disease
disease 8 15 1148 1155 I-chronic_disease

other 0 5 1156 1161 O
autoimmune 6 16 1162 1172 B-chronic_disease
and 17 20 1173 1176 I-chronic_disease
chronic 21 28 1177 1184 I-chronic_disease
inflammatory 29 41 1185 1197 I-chronic_disease
diseases 42 50 1198 1206 I-chronic_disease
( 51 52 1207 1208 O
i.e. 52 56 1208 1212 O
inflammatory 57 69 1213 1225 B-chronic_disease
bowel 70 75 1226 1231 I-chronic_disease
disease 76 83 1232 1239 I-chronic_disease
, 83 84 1239 1240 O
sarcoidosis 85 96 1241 1252 B-chronic_disease
) 96 97 1252 1253 O

pregnancy 0 9 1254 1263 B-pregnancy

sulfa 0 5 1264 1269 B-allergy_name
allergy 6 13 1270 1277 O

uncompensated 0 13 1278 1291 B-chronic_disease
Congestive 14 24 1292 1302 I-chronic_disease
Heart 25 30 1303 1308 I-chronic_disease
Failure 31 38 1309 1316 I-chronic_disease
( 39 40 1317 1318 I-chronic_disease
CHF 40 43 1318 1321 I-chronic_disease
) 43 44 1321 1322 I-chronic_disease

women 0 5 1323 1328 B-gender
≥ 6 7 1329 1330 O
50 8 10 1331 1333 B-lower_bound
years 11 16 1334 1339 I-lower_bound

